0000950170-23-009170.txt : 20230322 0000950170-23-009170.hdr.sgml : 20230322 20230322160650 ACCESSION NUMBER: 0000950170-23-009170 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230320 FILED AS OF DATE: 20230322 DATE AS OF CHANGE: 20230322 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tereau Daniel R CENTRAL INDEX KEY: 0001665985 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-05075 FILM NUMBER: 23752977 MAIL ADDRESS: STREET 1: 940 WINTER STREET STREET 2: PERKINELMER CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PERKINELMER INC CENTRAL INDEX KEY: 0000031791 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 042052042 STATE OF INCORPORATION: MA FISCAL YEAR END: 1229 BUSINESS ADDRESS: STREET 1: 940 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781-663-5791 MAIL ADDRESS: STREET 1: 940 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: EG&G INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: EDGERTON GERMESHAUSEN & GRIER INC DATE OF NAME CHANGE: 19670626 4 1 ownership.xml 4 X0407 4 2023-03-20 false 0000031791 PERKINELMER INC PKI 0001665985 Tereau Daniel R 940 WINTER STREET WALTHAM MA 02451 false true false false Please See Remarks false Common Stock 2023-03-20 4 M false 3750 52.65 A 22352 D Common Stock 2023-03-20 4 S false 15 121.69 D 22337 D Common Stock 2023-03-20 4 S false 5122 123.37 D 17215 D Common Stock 2023-03-20 4 S false 5304 124.01 D 11911 D Common Stock 2023-03-20 4 S false 300 124.79 D 11611 D NQ Stock Option (right to buy) 52.65 2023-03-20 4 M false 3750 0 D 2024-02-07 Common Stock 3750 0 D The Exercise Price included on the Form 4 filed on February 8, 2017 for the Reporting Person was incorrectly reported due to administrative error. The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by Mr. Tereau on February 16, 2023. The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $121.66 to $121.74. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $122.74 to $123.72. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $123.74 to $124.73. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $124.74 to $124.81. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. This option became exercisable in three equal annual installments beginning on February 7, 2018, which was the first anniversary of the date on which the option was granted. Senior Vice President, Strategy and Business Development /s/ John L. Healy (POA on file) for Daniel R. Tereau 2023-03-22